Modifiable lifestyle risk factors for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 20, Issue 3, 2010, Pages 803-811

  Flicker, Leon ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alzheimer's disease; lifestyle; older people; prevention

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; HOMOCYSTEINE; OLIVE OIL; POLYPHENOL; PYRIDOXINE; RESVERATROL; TRACE ELEMENT; VEGETABLE OIL;

AEROBIC EXERCISE; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ATTENTION; BRAIN PERFUSION; CENTRAL GRAY MATTER; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; CYANOCOBALAMIN DEFICIENCY; DAIRY PRODUCT; DEMENTIA; DIET RESTRICTION; EDUCATIONAL STATUS; FISH; FOOD INTAKE; HUMAN; LIFESTYLE MODIFICATION; MEAT; MEDITERRANEAN DIET; MEMORY; MOTOR CORTEX; NERVE CELL PLASTICITY; NEUROPATHOLOGY; PHYSICAL ACTIVITY; POULTRY; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; RISK REDUCTION; SOCIAL LIFE; VITAMIN INTAKE; WALKING;

EID: 77954546642     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091624     Document Type: Review

References (51)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117.
2. Jones GM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108, 485-494.
3. Newhouse PA, Potter A, Levin ED (1997) Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Drugs Ageing 11, 206-228.
4. Lee PN (1994) Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13, 131-144.
5. van Duijn CM, Clayton DG, Chandra V, Fratiglioni L, Graves AB, Heyman A (1994) Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case - control studies. Genetics Epidemiology 11, 539-551.
6. Riggs JE (1993) Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 342, 793-794.
7. Almeida OP, Hulse GK, Lawrence D, Flicker L (2002) Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 97, 15-28.
8. Anstey KJ, von Sanden C, Salim A, O'Kearney R (2007) Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies Am J Epidemiol 166, 367-378.
9. Almeida OP, Garrido GJ, Lautenschlager NT, Hulse GK, Jamrozik K, Flicker L (2008) Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease Am J Geriatr Psychiatry 16, 92-98.
10. Stead LF, Bergson G, Lancaster T (2008) Physician advice for smoking cessation. Cochrane Database Syst Rev, CD000165.
11. Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, CD000146.
12. Tait RJ, Hulse GK, Waterreus A, Flicker L, Lautenschlager NT, Jamrozik K, Almeida OP (2010) Two-year outcomes from a cessation of smoking intervention in older adults J Smoking Cessation 102, 148-155.
13. Pietropaolo S, Sun Y, Li R, Brana C, Feldon J, Yee BK (2008) The impact of voluntary exercise on mental health in rodents: a neuroplasticity perspective Behav Brain Res 192, 42-60.
14. Hamer M, Chida Y (2009) Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 39, 3-11.
15. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Bianchin M, Dalmonte E (2008) Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology 70, 1786-1794.
16. Angevaren M, Aufdemkampe G,Verhaar HJJ, Aleman A,Vanhees L (2008) Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev, CD005381.
17. van Uffelen JG, Chinapaw MJ, van Mechelen W, Hopman- Rock M (2008) Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br J Sports Med 42, 344-351.
18. Williamson JD, Espeland M, Kritchevsky SB, Newman AB, King AC, Pahor M, Guralnik JM, Pruitt LA, Miller ME, LIFE Study Investigators (2009) Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study. J Gerontol A Biol Sci Med Sci 64, 688-694.
19. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, Almeida OP (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial JAMA 300, 1027-1037.
20. Liu-Ambrose T, Nagamatsu L, Hsu L, Ashe M, Katarynych L, Khan K, Graf P, Beattie B, Handy T (2009) The effect of resistance training on brain function among communitydwelling senior women: a randomized controlled trial J Nutr Health Aging 13 (Suppl 1), S170.
21. Borenstein AR, Copenhaver CI, Mortimer JA (2006) Earlylife risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 20, 63-72.
22. Anstey K, Christensen H (2000) Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology 46, 163-177.
23. Muniz-Terrera G, Matthews F, Dening T, Huppert FA, Brayne C; CC75C Group (2009) Education and trajectories of cognitive decline over 9 years in very old people: methods and risk analysis Age Ageing 38, 277-282.
24. Wilson RS, Hebert LE, Scherr PA, Barnes LL, Mendes de Leon CF, Evans DA (2009) Educational attainment and cognitive decline in old age. Neurology 72, 460-465.
25. Gatz M, Prescott CA, Pedersen NL (2006) Lifestyle risk and delaying factors. Alzheimer Dis Assoc Disord 20 (Suppl 2), S84-S88.
26. de la Torre JC (1997) Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 43, 26-43.
27. Fratiglioni L, Paillard-Borg S,WinbladB (2004)An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3, 343-353.
28. Saczynski JS, Pfeifer LA, Masaki K,Korf ES, Laurin D, White L, Launer LJ (2006) The effect of social engagement on incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 163, 433-440.
29. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A (2003) Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev, CD003260.
30. Belleville S (2008) Cognitive training for persons with mild cognitive impairment. Int Psychogeriatr 20, 57-66. (Pubitemid 350256068)
31. Kinsella GJ, Mullaly E, Rand E, Ong B, Burton C, Price S, Phillips M, Storey E (2009) Early intervention for mild cognitive impairment: a randomised controlled trial. J Neurol Neurosurg Psychiatry 80, 730-736.
32. Valenzuela M, Sachdev P (2009) Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry 17, 179-187.
33. Willis SL, Tennstedt SL, Marsiske M, Ball K, Elias J, Koepke KM, Morris JN, Rebok GW, Unverzagt FW, Stoddard AM, Wright E; ACTIVE Study Group (2006) Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 296, 2805-2814.
34. Langbaum JB, Rebok GW, Bandeen-Roche K, Carlson MC (2009) Predicting memory training response patterns: results from ACTIVE. J Gerontol B Psychol Sci Soc Sci 64, 14-23.
35. Carlson MC, Saczynski JS, Rebok GW, Seeman T, Glass TA, McGill S, Tielsch J, Frick KD, Hill J, Fried LP (2008) Exploring the effects of an "everyday" activity program on executive function and memory in older adults: Experience Corps. Gerontologist 48, 793-801.
36. Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP (2005) Dementia associated with alcohol and other drug use. Int Psychogeriatr 17 Suppl 1, S109-S127.
37. Loxley W, Toumbourou J, Stockwell TR, Haines B, Scott K, Godfrey C,Waters E, Patton G, Fordham RJ, Gray D, Marshall J, Ryder D, Saggers S, Williams J, Sanci L (2004) The Prevention of Substance Use, Risk and Harm in Australia: A review of the Evidence. National Drug Research Institute and the Centre for Adolescent Health. Commonwealth of Australia.
38. NHMRC (2009) Australian guidelines to reduce health risks from drinking alcohol. Commonwealth of Australia.
39. Belleville J (2002) The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases Nutrition 18, 173-177.
40. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in Alzheimer's disease BMC Neurosci 9 (Suppl 2), S6.
41. Peters R, Peters J, Warner J, Beckett N, Bulpitt C (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37, 505-512.
42. Van Dam F, Van Gool WA (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review Arch Gerontol Geriatr 48, 425-430.
43. Flicker L, Vasikaran SD, Thomas J, Acres JM, Norman P, Jamrozik K, Hankey GJ, Almeida OP (2006) Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia Stroke 37, 547-549.
44. Malouf R, Grimley Evans J (2008) Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev, CD004514.
45. Durga J, Van Boxtel MPV, Schouten EG, Kok FJ, Katan MB, Verhoef P (2007) Effect of 3-year folic acid supplementation on cognition function in older adults in the FACIT trial a randomized double blind controlled trial. Lancet 369, 208-216.
46. Gillette Guyonnet S, AbellanVan Kan G, Andrieu S, Barberger Gateau P, Berr C, BonnefoyM, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B (2007) IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 11, 132-152.
47. Isaac MG, Quinn R, Tabet N (2008) Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev, CD002854.
48. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857.
49. Lim WS, Gammack JK, Van Niekerk J, Dangour AD (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev, CD00537.
50. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebocontrolled study. Prog Neuropsychopharmacol Biol Psychiatry 32, 1538-1544.
51. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA (2006) Mediterranean diet and risk for Alzheimer's disease Ann Neurol 59, 912-921. (Pubitemid 43830923)